Physician
Ebie, Nyambi
Ebie, Nyambi was paid $146K by Medicaid between Jan 2018 and Aug 2024, across 4 billing codes. Its largest line is 99232, hospital visit by a doctor, follow-up day — 45% of everything it billed.
33Billing provider infoEBIE, NYAMBI
CHICAGO, IL 60617
CHICAGO, IL 60617
33aNPI1548234883assigned 02/14/2006
33bProvider typeHematology & Oncology Physician
28Total paid$146K
24GClaims4,618
24DCodes billed4
24AFirst – last monthJan 2018 – Aug 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Illinois
Rank by total paid#32 of 285
Median peer was paid$31K
This provider vs. median4.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 326 | $4K | |
| 2019 | 349 | $5K | |
| 2020 | 1,361 | $28K | |
| 2021 | 469 | $16K | |
| 2022 | 867 | $41K | |
| 2023 | 970 | $36K | |
| 2024incomplete | 276 | $16K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 45% | 2,893 | 413 | $65K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 30% | 1,164 | 197 | $44K |
| 99223 | Prolong inpt eval add15 m | 25% | 508 | 460 | $37K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 53 | 38 | $448.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.